Chromatin immunoprecipitation informative brochure published by Porvair Sciences

Published on September 4, 2014 at 11:04 AM · No Comments

Porvair Sciences has published an informative 8-page brochure providing scientists with a background to Chromatin Immunoprecipitation (ChIP), an introduction to Chromatrap® ChIP assay technology and how Chromatrap® compares to traditional bead based methodologies.

Chromatrap®, the novel solid-based matrix for ChIP assays, available from Porvair Sciences, has been successfully used to isolate high quality chromatin from a wide range of biological matrices by research groups around the world (see www.chromatrap.com).

Chromatrap® uses a solid phase porous polymer functionalised with either protein A or G, allowing the chromatin capture to be more sensitive and efficient than bead based methods. The Chromatrap spin column approach offers significant advantages; including shortened protocol length (ChIP in under 5 h), less manual handling and sampling loss when compared to other methods based on sepharose or magnetic beads. Two formats are available, single spin column and 96 well microplate high throughput devices, both with excellent DNA enrichment for samples between 50ng-7000ng.

Chromatin Immunoprecipitation brochure

For a copy of the new brochure ‘A more efficient, sensitive and robust method of chromatin immunoprecipitation’ please visit the downloads section of www.chromatrap.com or contact Porvair Sciences on +44-1978-666239 or int.sales@porvairsciences.com.

Established in 1992, Porvair Sciences Ltd. has developed internationally recognised expertise in microplate technology and manufacturing serving applications in Drug Discovery, Combinatorial Chemistry, Solid Phase Extraction, Protein Purification, High Throughput Screening, Environmental Analysis, Proteomics and Genomics. Porvair Sciences Ltd. is a wholly owned subsidiary of Porvair plc.

Posted in: Medical Science News

Tags: , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Study suggests potential treatment for cardiovascular disease in people with apoE4 gene variant